About Osstem
Osstem is a company based in Seoul (South Korea) founded in 2006 by LIM Daniel was acquired by MBK Partners in January 2024. Osstem has completed 2 acquisitions, including CARDIOTEC and Implacil De Bortoli. Osstem operates in a competitive market with competitors including Convergent Dental, Keystone Dental, BioHorizons, Neoss and iDentical, among others.
- Headquarter Seoul, South Korea
- Founders LIM Daniel
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Mubadala
& 2 more
-
Employee Count
Not available
-
Investments & Acquisitions
CARDIOTEC
& 1 more
-
Acquired by
MBK Partners
(Jan 24, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Osstem
Unlock access to complete
Funding Insights of Osstem
Investors in Osstem
Osstem has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Mubadala, MBK Partners and Unison Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Sovereign wealth fund of United Arab Emirates
|
Locked | Locked | Locked |
Investor details for Osstem
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Osstem
Osstem has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include CARDIOTEC and Implacil De Bortoli.
Investment portfolio details for Osstem
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Drug-eluting stents and PTCA catheters are manufactured for cardiovascular conditions.
|
Locked | Locked | 1994 | Locked | |
|
Manufacturer of bone and tissue level implants for dental industry
|
Locked | Locked | 1981 | Locked |
Complete acquisition details for Osstem
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Osstem
Detailed financials for Osstem
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Osstem Comparisons
Peer comparison for Osstem
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Osstem
Osstem operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Convergent Dental, Keystone Dental, BioHorizons, Neoss and iDentical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Dental CO2 laser for soft and hard tissue application
|
|
| Locked | Locked | Locked |
Dental implants and biomaterials are developed by Keystone Dental.
|
|
| Locked | Locked | Locked |
Dental implant technologies and tissue regeneration products are developed.
|
|
| Locked | Locked | Locked |
Dental implant solutions are provided for patients and professionals.
|
|
| Locked | Locked | Locked |
Provider of a developer of personalized, drill-free dental implants that offers a safer, faster, and more affordable solution for tooth replacement compared to traditional dental implants
|
Detailed competitors of Osstem
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Osstem
Complete news archive for Osstem
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Osstem
Osstem was founded in 2006 and raised its 1st funding round 17 years after it was founded.
Osstem is headquartered in Seoul, South Korea.
Tae Gwan Uhm is the current CEO of Osstem.
Osstem Implant was founded in 2006 in Seoul, South Korea, and operates in the dental sector. Implants such as TS and MS models, along with LAS-kit and CAS-kit, are produced and supplied to over 50 countries. Education programs on dental implants are also provided to support awareness and adoption. Leadership includes roles held by Co-Founder LIM Daniel, CEO Tae Gwan Uhm, and CEO Director Cruise Kim.
Osstem's top competitors include Neoss, Keystone Dental and Nobel Biocare.
Osstem has made 2 acquisitions, including CARDIOTEC, and Implacil De Bortoli.
Osstem has 3 investors. Key investors include Mubadala, MBK Partners, and Unison Partners.